Adamax Peptide Peptide

Adamax is a modified synthetic derivative of Semax, widely used in preclinical research to investigate enhanced blood-brain barrier penetration, increased enzymatic stability, potentiation of the hepatocyte growth factor/c-Met pathway, and neuronal survival signaling. The adamantane group added to the N-terminus confers significantly greater resistance to enzymatic degradation and greater lipophilicity than the parent Semax analogs. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications.

Engineered solely for preclinical investigations, each batch of Adamax undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification.

Scientific Overview

Adamax potentiates HGF activity at the c-Met receptor and influences neurotrophic pathways in research settings. Preclinical investigations have examined Adamax in the following areas:

• Modulation of BDNF levels and TrkB receptor expression in hippocampal models
• Examination of synaptogenesis and dendritic arborization in neuronal cultures
• Investigation of synaptic signaling parameters in impairment paradigms
• Analysis of neuroplasticity and neuronal survival markers in stress-induced or age-related cellular models
• Observation of neurotransmitter balance and synaptic protein expression in vitro

Why Researchers Choose Our Adamax

For laboratories requiring dependable Adamax research peptide, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

• Purity ≥99% by HPLC
• Structural identity via mass spectrometry
• Third-party Certificate of Analysis (CoA) available per lot

For Research Use Only. Not for human use.

Statements regarding Adamax have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Explore our testing protocols in About Peptides > Rigorous Testing.

Research-Referenced Functional Attributes (Based on existing preclinical and literature data—not intended as claims of therapeutic use)

• Potentiation of HGF/c-Met signaling examined in relation to synaptogenesis and dendritic spine formation in neuronal models
• Investigation of PI3K/AKT pathway modulation in APP/PS1 transgenic mouse models
• Increased efficiency in blood-brain barrier crossing and enzymatic stability due to adamantane modification.
• Utility in investigations of neuroregenerative mechanisms in scopolamine-induced impairment studies
• Examination of synaptic protein expression markers in stress-challenged cellular systems
• Analysis of prolonged in vivo duration and selectivity compared to parent Semax analogs